Enregistrement :
18
de
43
(2011-07-01
à
2011-08-15)
Politique ou Programme
Health Canada's Blue Print for Renewal: Transforming Canada's Approach to Regulating Health Products and Food to renew the process for approving drugs. Merck Canada seeking to ensure that Canada's safety system for medicines ensures safe and effective medicines for Canadians in a timely manner, consistent with other jurisdictions.
Patented Medicine Prices Review Board (PMPRB) Pricing Guidelines used by the PMPRB to ensure that prices of patented medicines sold in Canada are not excessive. Merck Canada seeking to ensure PMPRB Guidelines reflect their mandate of ensuring prices are non-excessive, while ensuring an attractive climate for pharmaceutical research.
The Government's Science and Technology (S&T) Strategy announced in May 2007 which encourages a more competitive Canadian economy and improved quality of life for Canadians through science and technology. Merck Canada seeking to ensure S&T Strategy encourages a more competitive environment for biopharmaceutical innovation in Canada.
The National Pharmaceutical Strategy as agreed to by First Ministers in 2004, with a focus on options for catastrophic pharmaceutical coverage. Merck Canada seeking to ensure that Canadians' ability to access the medicines they need is increased.
Politique ou Programme, Règlement
Canada's Access to Medicine Regime (CAMR) and its Regulations which provide a framework within which eligible developing countries can import less expensive generic versions of patented drugs and medical devices. Merck Canada seeking to ensure that those threatened by serious diseases have timely access to medicines for the diseases and that a research climate that will help to produce cures for other diseases is maintained. Canada's Access to Medicines Regime Regulations.
Proposition législative, Projet de loi ou résolution
Canada's Food and Consumer Safety Action Plan proposes a series of initiatives to modernize and strengthen Canada's safety system for food, health and consumer products. Merck Canada seeking to ensure that Canada's safety system for medicines ensures safe and effective medicines for Canadians in a timely manner, consistent with other jurisdictions.
Règlement
Health Canada Health Products and Foods Branch Cost Recovery Proposal for Human Drug User Fees. Merck Canada seeking to ensure that renewed user fees adequately fund a safe and efficient review process. Food and Drug Regulation.
Patented Medicine Prices Review Board (PMPRB) Regulations identifying information to be reported to the PMPRB. Merck Canada seeking to ensure that the information being collected is consistent with PMPRB's mandate to prevent excessive pricing while ensuring an attractive climate for pharmaceutical research.
Patented Medicines (Notice of Compliance) Regulations which seek to balance patent rights and cost savings. Merck Canada seeking to ensure that patent rights are respected and are internationally competitive.
Subvention, Contribution ou autre avantage financier
National Immunization Strategy. Advocacy to seek continued funding in vaccines.